Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Rituximab is effective in the treatment of rheumatoid arthritis irrespective of body mass index: up to 48 weeks results from phase 3 study.
- Authors
- 유대현
- Issue Date
- 7-Nov-2017
- Place
- San Diego, USA
- Conference Name
- ACR 2017
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.